Visuals and interfaces are illustrative. Use cases shown are examples of how continuous glucose data may be incorporated into partner health experiences and are not medical advice or claims of diagnosis, treatment or prevention. References to CxM, additional analytes and future functionality describe development plans, not currently available or approved functionality. Product specifications, availability, intended use and regulatory status may vary by market. Supporting evidence is available from FiberSense on request.